SCHEMBL24362111

SCHEMBL24362111

c1ccc(-c2ccc(N(c3cccc(-c4cc5ccccc5c5ccccc45)c3)c3ccc4c(c3)oc3cc5ccccc5cc34)cc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 1/20 0.34
▸ GPR84 Q9NQS5 5/20 0.33
▸ CYP1A1 P04798 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP1B1 Q16678 1/20 0.31
▸ ALOX5 P09917 1/20 0.31
▸ MEN1 O00255 2/20 0.31
▸ KMT2A Q03164 2/20 0.31
▸ KDM4E B2RXH2 2/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ MAPT P10636 2/20 0.31
▸ HPGD P15428 2/20 0.31
▸ MPI P34949 1/20 0.31
▸ THRB P10828 1/20 0.31
▸ RECQL P46063 1/20 0.31
▸ BLM P54132 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.30
▸ ALOX15 P16050 1/20 0.30
▸ TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26020517 0.98 CYP11B1 (0.33) CYP11B1GPR84CYP1A1CYP1A2CYP1B1
SCHEMBL26020737 0.97 GPR84 (0.33) CYP11B1GPR84MEN1KMT2AKDM4E
SCHEMBL26020792 0.97 GPR84 (0.34) CYP11B1GPR84CYP1A1CYP1A2CYP1B1
SCHEMBL24361674 0.97 GPR84 (0.34) CYP11B1GPR84CYP1A1CYP1A2CYP1B1
SCHEMBL24361317 0.97 GPR84 (0.34) CYP11B1GPR84CYP1A1CYP1A2CYP1B1
SCHEMBL26020738 0.95 CYP11B1 (0.34) CYP11B1GPR84CYP1A1CYP1A2CYP1B1
SCHEMBL26020729 0.95 GPR84 (0.34) CYP11B1GPR84CYP1A1CYP1A2CYP1B1
SCHEMBL26022034 0.95 ALDH1A1 (0.33) GPR84ALDH1A1HPGDL3MBTL1TSHR
SCHEMBL24361672 0.94 GPR84 (0.37) CYP11B1GPR84ALOX5MEN1KMT2A
SCHEMBL24361596 0.94 GPR84 (0.37) CYP11B1GPR84ALOX5MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242498-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2023-08-03 — — US disclosed
US-20230242498-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2023-08-03 — — US disclosed
WO-2022086168-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2022-04-28 — — WO disclosed
WO-2022086171-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2022-04-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242498-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CRY2, NR1D1 CYP11B1 469/4885GPR84 1568/4885CYP1A1 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback